Application of biological marker to breast cancer

The invention discloses application of a biological marker to the breast cancer. The biological marker is lncRNA. Up-regulated expression of LINC01781 and LINC02014 in the breast cancer is found for the first time, whether a testee suffers from the breast cancer or not and the risk of the testee suf...

Full description

Saved in:
Bibliographic Details
Main Authors WU QI, WANG YALI, YUAN CHENGLIANG, WEI WEI, JIA XINJIAN
Format Patent
LanguageChinese
English
Published 31.05.2019
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
ENZYMOLOGY
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
METALLURGY
MICROBIOLOGY
MUTATION OR GENETIC ENGINEERING
PROCESSES OF PREPARING SUCH COMPOSITIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The invention discloses application of a biological marker to the breast cancer. The biological marker is lncRNA. Up-regulated expression of LINC01781 and LINC02014 in the breast cancer is found for the first time, whether a testee suffers from the breast cancer or not and the risk of the testee suffering from the breast cancer can be judged by detecting the expression level of LINC01781 and LINC02014. Meanwhile, a gene target is provided for treating the breast cancer. 本发明公开了生物标志物在乳腺癌中的应用，所述生物标志物为lncRNA。本发明首次发现了LINC01781和LINC02014在乳腺癌中表达上调，通过检测LINC01781和LINC02014的表达水平可以判断受试者是否患有乳腺癌以及患乳腺癌的风险。本发明同时为乳腺癌的治疗提供了基因靶点。
Bibliography:Application Number: CN201910298889